Global burden of hematologic malignancies and evolution patterns over the past 30 years
-
By
-
Nan Zhang
-
Jinxian Wu
-
Qian Wang
-
Yuxing Liang
-
Xinqi Li
-
Guopeng Chen
-
Linlu Ma
-
Xiaoyan Liu
-
Fuling Zhou
-
May 17, 2023
-
Clinical Scorecard: Worldwide Impact of Hematologic Cancers and Trends Over the Last Three Decades
At a Glance
| Category | Detail |
|---|
| Condition | Hematologic malignancies including leukemia, multiple myeloma, non-Hodgkin lymphoma, and Hodgkin lymphoma |
| Key Mechanisms | Disruption of normal hematopoietic function leading to myeloid and lymphatic tumors |
| Target Population | Global population across 204 countries and territories, stratified by age, sex, and socio-demographic index |
| Care Setting | Health systems worldwide with emphasis on epidemiological surveillance and healthcare planning |
Key Highlights
- Incidence of leukemia is declining globally but rising in some developed countries.
- Survival rates for hematologic malignancies have improved dramatically over the past decades.
- Epidemiological data from the Global Burden of Disease study provide comprehensive incidence and mortality trends from 1990 to 2019.
Guideline-Based Recommendations
Diagnosis
- Use WHO and ICD-10 classifications to identify hematologic malignancy subtypes including AML, ALL, CML, CLL, MM, NHL, and HL.
Management
- Develop targeted prevention strategies based on regional and socio-demographic epidemiological patterns.
Monitoring & Follow-up
- Utilize Global Burden of Disease data and Bayesian meta-regression tools (DisMod-MR 2.1) for consistent incidence and mortality projections.
- Monitor trends by subtype, sex, age, and socio-demographic index to inform healthcare decision-making.
Risks
- Assess risk factors using comparative risk assessment framework including relative risk, exposure distribution, and population attributable fractions.
Patient & Prescribing Data
Patients diagnosed with hematologic malignancies worldwide, stratified by subtype and demographic factors.
Epidemiological trends and survival improvements support the need for region-specific prevention and management approaches.
Clinical Best Practices
- Incorporate comprehensive epidemiological data to guide healthcare planning and resource allocation.
- Recognize regional and socio-demographic variations in hematologic malignancy incidence and mortality.
- Apply standardized disease classification systems for accurate diagnosis and reporting.
- Use risk factor assessment frameworks to identify and mitigate modifiable risks.
References
